EQT Corp. (EQT) announced on Wednesday that its EQT Healthcare Growth Strategy and the EQT Growth Fund have agreed to acquire a majority stake in CluePoints, a Belgium-based company. Summit Partners, a current investor in CluePoints, along with Clinimetrics SA, a co-founder of the company, will retain minority stakes. The financial details of the transaction have not been disclosed.
CluePoints specializes in a cloud-based software platform for Risk-Based Quality Management and data quality oversight in clinical trials. Utilizing proprietary algorithms, CluePoints provides comprehensive solutions from initial risk identification to continuous tracking and monitoring of issues and discrepancies throughout the drug development process.
The transaction is anticipated to close in the third quarter.
